(Q35219026)

7 August 2017

1 reference

title

Cancer vaccines: between the idea and the reality (English)

1 reference

7 August 2017

Olivera J Finn

1

1 reference

7 August 2017

1 August 2003

1 reference

Nature Reviews Immunology

7 August 2017

1 reference

7 August 2017

3

1 reference

7 August 2017

630-641

1 reference

7 August 2017

8

1 reference

https://scigraph.springernature.com/pub.10.1038/nri1150

7 August 2017

0 references

cites work

Vaccinology: past achievements, present roadblocks and future promises

1 reference

Immunotherapeutic potential of whole tumour cells.

31 March 2020

1 reference

Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: a phase I trial of safety and immune activation

31 March 2020

1 reference

GM-CSF-based cancer vaccines

31 March 2020

1 reference

Immunotherapy with dendritic cells directed against tumor antigens shared with normal host cells results in severe autoimmune disease

31 March 2020

1 reference

Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytes.

31 March 2020

1 reference

Elucidating the autoimmune and antitumor effector mechanisms of a treatment based on cytotoxic T lymphocyte antigen-4 blockade in combination with a B16 melanoma vaccine: comparison of prophylaxis and therapy

31 March 2020

1 reference

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

31 March 2020

1 reference

Prevention of spontaneous neu-expressing mammary tumor development in mice transgenic for rat proto-neu by DNA vaccination.

31 March 2020

1 reference

Three different vaccines based on the 140-amino acid MUC1 peptide with seven tandemly repeated tumor-specific epitopes elicit distinct immune effector mechanisms in wild-type versus MUC1-transgenic mice with different potential for tumor rejection

31 March 2020

1 reference

Tumor-specific shared antigenic peptides recognized by human T cells

31 March 2020

1 reference

Cancer/testis antigens: an expanding family of targets for cancer immunotherapy

31 March 2020

1 reference

Generation of T-cell immunity to the HER-2/neu protein after active immunization with HER-2/neu peptide-based vaccines

31 March 2020

1 reference

Mammaglobin-A is a tumor-associated antigen in human breast carcinoma

31 March 2020

1 reference

Strategies for the development of recombinant vaccines for the immunotherapy of breast cancer

31 March 2020

1 reference

Identification of cyclin B1 as a shared human epithelial tumor-associated antigen recognized by T cells

31 March 2020

1 reference

31 March 2020

Vaccines and melanoma

1 reference

Spontaneous adenocarcinoma mouse models for immunotherapy

31 March 2020

1 reference

Dendritic cell/peptide cancer vaccines: clinical responsiveness and epitope spreading

31 March 2020

1 reference

Use of cellular and cytokine adjuvants in the immunotherapy of cancer

31 March 2020

1 reference

CpG DNA: security code for host defense

31 March 2020

1 reference

CpG-A Oligonucleotides Induce a Monocyte-Derived Dendritic Cell-Like Phenotype That Preferentially Activates CD8 T Cells

31 March 2020

1 reference

Lipoproteins take their toll on the host

31 March 2020

1 reference

Toll-like receptor 2 ligands as adjuvants for human Th1 responses

31 March 2020

1 reference

A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules

31 March 2020

1 reference

Poly(lactide-co-glycolide) microparticles for the development of single-dose controlled-release vaccines

31 March 2020

1 reference

A recombinant virus-like particle system derived from parvovirus as an efficient antigen carrier to elicit a polarized Th1 immune response without adjuvant

31 March 2020

1 reference

Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs

31 March 2020

1 reference

Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses

31 March 2020

1 reference

Recent advances in mucosal vaccines and adjuvants

31 March 2020

1 reference

CCR6 mediates dendritic cell localization, lymphocyte homeostasis, and immune responses in mucosal tissue.

31 March 2020

1 reference

Mucosal addressin expression and binding-interactions with naive lymphocytes vary among the cranial, oral, and nasal-associated lymphoid tissues

31 March 2020

1 reference

Regulation of mucosal dendritic cell function by receptor activator of NF-kappa B (RANK)/RANK ligand interactions: impact on tolerance induction

31 March 2020

1 reference

The Toll receptor family and microbial recognition

31 March 2020

1 reference

TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties

31 March 2020

1 reference

Disease-associated bias in T helper type 1 (Th1)/Th2 CD4(+) T cell responses against MAGE-6 in HLA-DRB10401(+) patients with renal cell carcinoma or melanoma

31 March 2020

1 reference

First-line, single-agent Herceptin(trastuzumab) in metastatic breast cancer: a preliminary report

31 March 2020

1 reference

Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group

31 March 2020

1 reference

Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patients

31 March 2020

1 reference

Cancer immunotherapy with peptide-based vaccines: what have we achieved? Where are we going?

31 March 2020

1 reference

Immunological memory and protective immunity: understanding their relation

31 March 2020

1 reference

On differences between immunity and immunological memory

31 March 2020

1 reference

Differentiating between memory and effector CD8 T cells by altered expression of cell surface O-glycans

31 March 2020

1 reference

The number of long-lasting functional memory CD8+ T cells generated depends on the nature of the initial nonspecific stimulation.

31 March 2020

1 reference

Therapy of human tumors in NOD/SCID mice with patient-derived reactivated memory T cells from bone marrow.

31 March 2020

1 reference

Therapeutic vaccination against chronic viral infection: the importance of cooperation between CD4+ and CD8+ T cells

31 March 2020

1 reference

Long lasting p53-specific T cell memory responses in the absence of anti-p53 antibodies in patients with resected primary colorectal cancer.

31 March 2020

1 reference

Lineage relationship and protective immunity of memory CD8 T cell subsets

31 March 2020

1 reference

Decreased IL-2, IFN-gamma, and IL-10 production by aged mice during the acute phase of E55+ retrovirus infection

31 March 2020

1 reference

Defective generation but normal maintenance of memory T cells in old mice.

31 March 2020

1 reference

Age-dependent alterations in the tumoricidal functions of tumor-associated macrophages

31 March 2020

1 reference

Repertoire of antibody response in bone marrow and the memory response are differentially affected in aging mice

31 March 2020

1 reference

Age-dependent defects in TCR-triggered cytoskeletal rearrangement in CD4+ T cells

31 March 2020

1 reference

T cell subset patterns that predict resistance to spontaneous lymphoma, mammary adenocarcinoma, and fibrosarcoma in mice.

31 March 2020

1 reference

Low effectiveness of DNA vaccination against HER-2/neu in ageing

31 March 2020

1 reference

Defective T cell priming associated with aging can be rescued by signaling through 4-1BB (CD137).

31 March 2020

1 reference

CTLA-4: new insights into its biological function and use in tumor immunotherapy

31 March 2020

1 reference

Cancer immunoediting: from immunosurveillance to tumor escape

31 March 2020

1 reference

Human prostate cancer blocks the generation of dendritic cells from CD34+ hematopoietic progenitors

31 March 2020

1 reference

Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice

31 March 2020

1 reference

Where have all the T cells gone? Mechanisms of immune evasion by tumors

31 March 2020

1 reference

Interleukin-10 promotes B16-melanoma growth by inhibition of macrophage functions and induction of tumour and vascular cell proliferation.

31 March 2020

1 reference

Activated human CD4+ T cells induced by dendritic cell stimulation are most sensitive to transforming growth factor-beta: implications for dendritic cell immunization against cancer.

31 March 2020

1 reference

The role of cytokines in classical Hodgkin lymphoma

31 March 2020

1 reference

Indoleamine 2,3-dioxygenase contributes to tumor cell evasion of T cell-mediated rejection.

31 March 2020

1 reference

Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade

31 March 2020

1 reference

A push-pull approach to maximize vaccine efficacy: abrogating suppression with an IL-13 inhibitor while augmenting help with granulocyte/macrophage colony-stimulating factor and CD40L

31 March 2020

1 reference

Recovery of zeta-chain expression and changes in spontaneous IL-10 production after PSA-based vaccines in patients with prostate cancer

31 March 2020

1 reference

Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma

31 March 2020

1 reference

Cutting edge: control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells

31 March 2020

1 reference

Depletion of CD25+ regulatory cells uncovers immune responses to shared murine tumor rejection antigens

31 March 2020

1 reference

Immunogenicity of a polyvalent melanoma antigen vaccine in humans

31 March 2020

1 reference

Improved survival of patients with melanoma with an antibody response to immunization to a polyvalent melanoma vaccine

31 March 2020

1 reference

Treatment of metastatic melanoma with autologous, hapten-modified melanoma vaccine: regression of pulmonary metastases

31 March 2020

1 reference

Cytokine-secreting tumor cell vaccines

31 March 2020

1 reference

Vaccination of Metastatic Melanoma Patients With Autologous Tumor-Derived Heat Shock Protein gp96-Peptide Complexes: Clinical and Immunologic Findings

31 March 2020

1 reference

Vaccination with irradiated autologous tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor augments antitumor immunity in some patients with metastatic non-small-cell lung carcinoma

31 March 2020

1 reference

Dendritic cells: On the move from bench to bedside

31 March 2020

1 reference

Dendritic cells capture killed tumor cells and present their antigens to elicit tumor-specific immune responses

31 March 2020

1 reference

Induction of Polyclonal Prostate Cancer-Specific CTL Using Dendritic Cells Transfected with Amplified Tumor RNA

31 March 2020

1 reference

Induction of Tumor-Specific Cytotoxic T Lymphocytes in Cancer Patients by Autologous Tumor RNA-Transfected Dendritic Cells

31 March 2020

1 reference

DNA-based immunization by in vivo transfection of dendritic cells

31 March 2020

1 reference

Human tumor-derived genomic DNA transduced into a recipient cell induces tumor-specific immune responses ex vivo.

31 March 2020

1 reference

Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors

31 March 2020

1 reference

A phase I trial of a synthetic mucin peptide vaccine. Induction of specific immune reactivity in patients with adenocarcinoma

31 March 2020

1 reference

A phase I vaccine trial with peptides reflecting ras oncogene mutations of solid tumors.

31 March 2020

1 reference

Vaccination with HPV16 peptides of patients with advanced cervical carcinoma: clinical evaluation of a phase I-II trial

31 March 2020

1 reference

Phase I study in advanced cancer patients of a diversified prime-and-boost vaccination protocol using recombinant vaccinia virus and recombinant nonreplicating avipox virus to elicit anti-carcinoembryonic antigen immune responses

31 March 2020

1 reference

Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells.

31 March 2020

1 reference

Immunization with a HER-2/neu helper peptide vaccine generates HER-2/neu CD8 T-cell immunity in cancer patients

31 March 2020

1 reference

Immunisation of metastatic cancer patients with MAGE-3 protein combined with adjuvant SBAS-2: a clinical report

31 March 2020

1 reference

Prophylactic cancer vaccines

31 March 2020

1 reference

Success of vaccine offers promise of cervical cancer prevention

31 March 2020

1 reference

Strategies for HPV prevention

31 March 2020

1 reference

Nationwide vaccination: a success story in Taiwan.

31 March 2020

1 reference

Hepatitis B vaccination in infancy in The Gambia: protection against carriage at 9 years of age

31 March 2020

1 reference

Immunoprevention of colorectal cancer: a future possibility?

31 March 2020

1 reference

Antitumor vaccines: is it possible to prevent a tumor?

31 March 2020

1 reference

MUC-1 epithelial tumor mucin-based immunity and cancer vaccines

31 March 2020

1 reference

Presentation of MUC1 tumor antigen by class I MHC and CTL function correlate with the glycosylation state of the protein taken Up by dendritic cells

31 March 2020

1 reference

Complex carbohydrates are not removed during processing of glycoproteins by dendritic cells: processing of tumor antigen MUC1 glycopeptides for presentation to major histocompatibility complex class II-restricted T cells

31 March 2020

1 reference

Immunotherapy with mannan-MUC1 and IL-12 in MUC1 transgenic mice

31 March 2020

1 reference

Mice with spontaneous pancreatic cancer naturally develop MUC-1-specific CTLs that eradicate tumors when adoptively transferred

31 March 2020

1 reference

Induction of cellular immunity in chimpanzees to human tumor-associated antigen mucin by vaccination with MUC-1 cDNA-transfected Epstein-Barr virus-immortalized autologous B cells

31 March 2020

1 reference

Phase I study of recombinant CEA vaccinia virus vaccine with post vaccination CEA peptide challenge

31 March 2020

1 reference

Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic mice

31 March 2020

1 reference

The history of the development of vaccines for the treatment of lymphoma.

31 March 2020

1 reference

Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions

31 March 2020

1 reference

Preneoplastic prostate lesions: an opportunity for prostate cancer prevention

31 March 2020

1 reference

Colorectal polyps and other precursor lesions. Need for an expanded view

31 March 2020

1 reference

Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation

31 March 2020

1 reference

Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation

31 March 2020

1 reference

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations

31 March 2020

1 reference

Efficacy of Bilateral Prophylactic Mastectomy in Women with a Family History of Breast Cancer

31 March 2020

1 reference

Subcutaneous mastectomy data: a final statistical analysis of 1500 patients

31 March 2020

1 reference

Risk-reduction mastectomy: clinical issues and research needs

31 March 2020

1 reference

Flt3 ligand as a vaccine adjuvant in association with HER-2/neu peptide-based vaccines in patients with HER-2/neu-overexpressing cancers

31 March 2020

1 reference

Genetic predispositions to acute and chronic pancreatitis

31 March 2020

1 reference

Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group

31 March 2020

1 reference

Cigarette Smoking as a Risk Factor for Pancreatic Cancer in Patients With Hereditary Pancreatitis

31 March 2020

1 reference

Lessons from hereditary colorectal cancer

31 March 2020

1 reference

O-glycan biosynthesis in human colorectal adenoma cells during progression to cancer

31 March 2020

1 reference

Comparative study for histology, proliferative activity, glycoproteins, and p53 protein between old and recent colorectal adenomas in Japan

31 March 2020

1 reference

Human tumor antigens are ready to fly.

31 March 2020

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NRI1150

1 reference

PubMed ID

12974478

Dimensions Publication ID

7 August 2017

1031579889

0 references

Fatcat ID

release_nnr3fgz4d5aerkqz6kcfwsjjpu

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nnr3fgz4d5aerkqz6kcfwsjjpu

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

12974478

1 reference

PubMed ID

12974478